Clinical

Dataset Information

0

CtDNA as a Prognostic Marker for Postoperative Relapse in Early and Intermediate Stage Colorectal Cancer


ABSTRACT: By monitoring the serum ctDNA mutational profile using NGS, the present clinical trial aims to elucidate the correlation between the postoperative ctDNA status and the prognosis of patients with early and intermediate-stage colorectal cancer, and explore the possibility of clinical utility of serum ctDNA as a clinical index to predict postoperative relapse.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2256602 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2367246 | ecrin-mdr-crc
2021-12-23 | GSE163763 | GEO
| PRJEB5921 | ENA
| PRJNA1049192 | ENA
2015-04-30 | E-GEOD-67819 | biostudies-arrayexpress
| 2289240 | ecrin-mdr-crc
| PRJNA1031346 | ENA
2014-07-15 | E-MTAB-2393 | biostudies-arrayexpress
2010-06-09 | E-GEOD-2301 | biostudies-arrayexpress
2024-05-21 | PXD051904 | Pride